- Home
- ELOG vs ICCM Comparison
ELOG vs ICCM Comparison
Compare ELOG & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELOG | ICCM |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Integrated Freight & Logistics | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0M | 8.3M |
| IPO Year | 2024 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ELOG | ICCM |
|---|---|---|
| Price | $0.51 | $1.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 80.9K | ★ 92.8K |
| Earning Date | 07-17-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $139.51 |
| Revenue Next Year | N/A | $75.66 |
| P/E Ratio | $6.84 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.45 | $0.13 |
| 52 Week High | $3.07 | $9.54 |
Technical Indicators
Market Signals| Indicator | ELOG | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 27.42 | 33.81 |
| Support Level | $0.45 | $0.22 |
| Resistance Level | $0.98 | $2.50 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 19.19 | 12.73 |
Price Performance
Historical ComparisonAbout ELOG Eastern International Ltd. Ordinary Shares
Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.